Evidence map›Paper›PMID 38306457›Full record

ArticleMedical physics2024

Development of physiologically-informed computational coronary artery plaques for use in virtual imaging trials.

Thomas J Sauer, Andrew J Buckler, Ehsan Abadi, Melissa Daubert, Pamela S Douglas, Ehsan Samei, William P Segars

Open access · bronzeAbstract read
In one paragraph

Article in Medical physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Thomas J SauerCenter for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology, the Duke University Medical Center, Durham, North Carolina, USA.
Andrew J BucklerElucid Bioimaging, Inc., Boston, Massachusetts, USA.
Ehsan AbadiCenter for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology, the Duke University Medical Center, Durham, North Carolina, USA.
Melissa DaubertDuke Department of Medicine, the Duke University Medical Center, Durham, North Carolina, USA.
Pamela S DouglasDuke Department of Medicine, the Duke University Medical Center, Durham, North Carolina, USA.
Ehsan SameiCenter for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology, the Duke University Medical Center, Durham, North Carolina, USA.
William P SegarsCenter for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology, the Duke University Medical Center, Durham, North Carolina, USA.
Duke Medical Center · USElucid Bioimaging · US

Funding

TR&D Project 3: Virtual ReadersP41EB028744 · NIBIB · DUKE UNIVERSITY · PI Ehsan Samei · 2021 to 2026
$7.8M
Simulation Tools for Dynamic CTR01EB001838 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI SAMEI, EHSAN, SEGARS, WILLIAM P · 2005 to 2023
$6.9M
Precision Cardiac CT: Development of a Computational Platform for Optimizing ImagingR01HL131753 · NHLBI · DUKE UNIVERSITY · PI SAMEI, EHSAN, SEGARS, WILLIAM P · 2017 to 2020
$2.7M
NHLBI NIH HHS R01 HL131753NIBIB NIH HHS P41 EB028744NIBIB NIH HHS R01 EB001838
6 · The paper itself

Abstract

backgroundAs a leading cause of death, worldwide, cardiovascular disease is of great clinical importance. Among cardiovascular diseases, coronary artery disease (CAD) is a key contributor, and it is the attributed cause of death for 10% of all deaths annually. The prevalence of CAD is commensurate with the rise in new medical imaging technologies intended to aid in its diagnosis and treatment. The necessary clinical trials required to validate and optimize these technologies require a large cohort of carefully controlled patients, considerable time to complete, and can be prohibitively expensive. A safer, faster, less expensive alternative is using virtual imaging trials (VITs), utilizing virtual patients or phantoms combined with accurate computer models of imaging devices. PURPOSE: In this work, we develop realistic, physiologically-informed models for coronary plaques for application in cardiac imaging VITs.

methodsHistology images of plaques at micron-level resolution were used to train a deep convolutional generative adversarial network (DC-GAN) to create a library of anatomically variable plaque models with clinical anatomical realism. The stability of each plaque was evaluated by finite element analysis (FEA) in which plaque components and vessels were meshed as volumes, modeled as specialized tissues, and subjected to the range of normal coronary blood pressures. To demonstrate the utility of the plaque models, we combined them with the whole-body XCAT computational phantom to perform initial simulations comparing standard energy-integrating detector (EID) CT with photon-counting detector (PCD) CT.

resultsOur results show the network is capable of generating realistic, anatomically variable plaques. Our simulation results provide an initial demonstration of the utility of the generated plaque models as targets to compare different imaging devices.

conclusionsVast, realistic, and variable CAD pathologies can be generated to incorporate into computational phantoms for VITs. There they can serve as a known truth from which to optimize and evaluate cardiac imaging technologies quantitatively.

Indexed as

Coronary VesselsTomography, X-Ray ComputedComputer SimulationHeartHumansPhantoms, Imagingcardiac plaquecardiovascular diseasecomputer phantomcoronary artery diseasefinite element analysismedical imaging simulation

Identifiers

PMID38306457
PMCPMC11044179
OpenAlexW4391467709

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.